Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

por Kuo, Chun-Ting, Chen, Chen-Lin, Li, Chih-Chi, Huang, Guan-Syuan, Ma, Wei-Yuan, Hsu, Wei-Fan, Lin, Ching-Hung, Lu, Yen-Shen, Wo, Andrew M.
Publicado 2019

Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

por Kuo, Chun-Ting, Chen, Chen-Lin, Li, Chih-Chi, Huang, Guan-Syuan, Ma, Wei-Yuan, Hsu, Wei-Fan, Lin, Ching-Hung, Lu, Yen-Shen, Wo, Andrew M.
Publicado 2020